|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer
2
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
3
Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate Cancer
4
Improving End-of-Life Care: Making Hospice and Home Support Accessible
5
